Legal Counsel Jarosław Rudy advised the fund operated by Kvarko ASI sp. z o.o. on investments in Auxilius Pharma Oncology sp. z o.o.

Jarosław Rudy, Legal Counsel and Managing Partner of the Żyglicka and Wspólnicy Law Firm, advised Kvarko ASI sp. z o.o. on the investment in Auxilius Pharma Oncology sp. z o.o., which carries out a R&D project.

This is already the 20th joint investment.

The total value of funds acquired by Auxilius Pharma Oncology sp. z o.o. is PLN 1 million.

Auxilius Pharma Oncology Sp. z o.o. operates in the complex generics market in the field of oncology. After the R&D phase, the company plans sale in the USA (under the supervision of the FDA (U.S. Food and Drug Administration), and then in Europe (under the supervision of the EMA (European Medicines Agency).

Generics, as substitutes of original medications, must meet the same standards of quality, safety and effectiveness.